Glutathione levels and immune responses in tuberculosis patients

Microbial Pathogenesis

Volumn 44, Issue 3, 2008, Pages 255-261

  Venketaraman, Vishwanath ^a   Millman, Ariel ^a   Salman, Marwa ^a   Swaminathan, Shobha ^a   Goetz, Mary ^a   Lardizabal, Alfred ^a   David Hom, ^a   Connell, Nancy D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Glutathione; Tuberculosis immunity

Indexed keywords

ACETYLCYSTEINE; ETHAMBUTOL; GLUTATHIONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL REPRODUCTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS;

ACETYLCYSTEINE; ANTIGENS, BACTERIAL; GLUTATHIONE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 38549110678     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.09.002     Document Type: Article

References (23)

1. Kaufmann S.H.E. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 61 (2002) ii54-ii58
2. Cohn D.L., and El-Sadr W.M. Treatment of latent tuberculosis infection. In: Reichman L.B., and Hershfield E. (Eds). Tuberculosis: a comprehensive international approach. 2nd ed (2000), Marcel Dekker, New York 471-502
3. Buhl R., Jaffe H.A., Holroyd K.J., Wells F.B., Mastrangeli A., Saltini C., et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2 8675 (1989) 1294-1298
4. de Quay B., Malinverni R., and Lauterburg B.H. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6 8 (1992) 815-819
5. Eck H.P., Gmunder H., Hartmann M., Petzoldt D., Daniel V., and Droge W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler 370 2 (1989) 101-108
6. Helbling B., von Overbeck J., and Lauterburg B.H. Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest 26 (1996) 38-44
7. Spigelman M.K. New tuberculosis therapeutics: a growing pipeline. J Infect Dis 196 (2007) S28-S34
8. McIlleron H., Meintjes G., Burman W.J., and Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 196 (2007) S63-S75
9. Venketaraman V., Dayaram Y.K., Amin A.G., Ngo R., Green R.M., Talaue M.T., et al. Role of glutathione in macrophage control of mycobacteria. Infect Immun 71 4 (2003) 1864-1871
10. Venketaraman V., Dayaram Y.K., Talaue M.T., and Connell N.D. Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis. Infect Immun 73 3 (2005) 1886-1889
11. Dayaram Y.K., Talaue M.T., Connell N.D., and Venketaraman V. Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione. J Bacteriol 188 4 (2006) 1364-1372
12. Venketaraman V., Rodgers T., Linares R., Reilly N., Swaminathan S., Hom D., et al. Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects. AIDS Res Ther 3 5 (2006) 1-12
13. Dubey S.S., Sinha K.K., and Gupta J.P. Vitamin C status, glutathione and histamine in gastric carcinoma, tuberculous enteritis and non-specific ulcerative colitis. Indian J Physiol Pharmacol 29 2 (1985) 111-114
14. Vijayamalini M., and Manoharan S. Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct 22 1 (2004) 19-22
15. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 (1993) 2249-2252
16. Tsao T.C., Hong J., Li L.F., Hsieh M.J., Liao S.K., and Chang K.S. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 117 1 (2000) 103-109
17. Kwiatkowska S., Piasecka G., Zieba M., Piotrowski W., and Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis. Respir Med 93 4 (1999) 272-276
18. Jack C.I., Jackson M.J., and Hind C.R. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuber Lung Dis 75 2 (1994) 132-137
19. Rook G.A. Progress in the immunology of the mycobacterioses. Clin Exp Immunol 69 (1987) 1-9
20. Rothstein J.L., Lint T.F., and Schreiber H. Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5). J Exp Med 168 (1988) 2007-2021
21. Strieter R.M., Kunkel S.L., and Bone R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 21 (1993) S447-S463
22. Havlir D.V., Torriani F.J., Schrier R.D., et al. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol 39 (2001) 298-303
23. Coleman M.D., Aerry R., Wanogho E., Khan N.B., Lambert P.A., and Rathbone D.L. Effects of glutathione and N-acetyl cysteine on the antimycobacterial efficacy of isoniazid on Mycobacterium fortuitum in vitro. J Chemother 18 (2006) 665-666